v3.26.1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 1,425,364 $ 4,622,331
Short-term investment securities 1,688,355 2,698,661
Restricted cash 1,555,649 1,231,168
Interest receivable 16,014 35,129
Accounts receivable 1,302,439 1,090,297
Prepaid expenses and other current assets 418,943 219,067
Total current assets 6,406,764 9,896,653
Non-current assets:    
Long-term investment securities 109,416
Operating lease right-of-use asset, net 9,851 38,535
Other assets 10,500 10,537
Total assets 6,536,531 9,945,725
Current liabilities:    
Accounts payable 816,059 852,024
Accrued expenses 1,395,680 967,974
Deferred research and development obligations 1,564,172 1,730,852
Operating lease liability 5,054 34,621
Total current liabilities 3,882,765 3,687,271
Non-current liabilities:    
Total liabilities 8,923,775 8,713,315
Commitments and contingencies (Note 5)  
Stockholders’ equity:    
Preferred stock, $.0001 par value: Authorized shares - 5,000,000; none issued and outstanding
Common stock, $.001 par value: Authorized shares - 100,000,000; issued shares - 48,692,205 and 48,441,300, outstanding shares - 36,438,703 and 36,187,798 as of June 30, 2026, and December 31, 2025, respectively 48,693 48,442
Additional paid-in capital 114,023,653 113,564,991
Treasury stock shares held at cost - 12,253,502 (18,929,915) (18,929,915)
Accumulated deficit (97,529,675) (93,451,108)
Total stockholders’ (deficit) equity (2,387,244) 1,232,410
Total liabilities and stockholders’ equity 6,536,531 9,945,725
Nonrelated Party [Member]    
Current liabilities:    
Accrued interest 60,000 60,000
Non-current liabilities:    
Convertible notes, net of issuance costs 2,971,125 2,962,304
Related Party [Member]    
Current liabilities:    
Accrued interest 41,800 41,800
Non-current liabilities:    
Convertible notes, net of issuance costs $ 2,069,885 $ 2,063,740